Mach aus dieser Rolle ein Bewerbungsgespräch — ein Lebenslauf und ein Anschreiben, die darauf ausgerichtet sind, was dieser Arbeitgeber sucht.
The International PhD Programme (IPP) Mainz invites talented scientists to pursue a PhD in Life Sciences within a dynamic, international community. The program hosts projects ranging from proteostasis and aging to gene regulation and neural memory, offering exposure to cutting-edge techniques.
The PhD project emphasizes collaborative work, advanced training, and access to state-of-the-art facilities. Fully funded positions support your research journey and thesis completion.
Organisation/Company International PhD Programme (IPP) Mainz Department Institute of Molecular Biology Research Field Biological sciences Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 15 Oct 2026 - 12:00 (Europe/Berlin) Country Germany Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Thinking of doing your PhD in the Life Sciences? The International PhD Programme (IPP) Mainz is offering talented scientists the chance to work on cutting edge research projects . As an IPP PhD student, you will join a community of exceptional scientists working on diverse topics ranging from how organisms age or how our DNA is repaired, to how epigenetics regulates cellular identity or neural memory.
Activities and responsibilities
The research group of Anton Khmelinskii in collaboration with Jan Padeken offers the following PhD project:
The progressive deterioration of protein homeostasis (proteostasis) is a primary hallmark of aging. As organisms age, the functionality of the proteostasis network, comprised of molecular chaperones, the ubiquitin-proteasome system and autophagy, declines, leading to the accumulation of misfolded and aggregated proteins that compromise cellular viability. Proteostatic decline is not merely a consequence of aging but an early, causal event whereby loss of proteostasis precedes and predicts organismal decline, and its onset is sufficient to accelerate aging. Conversely, genetic or pharmacological enhancement of proteostasis network capacity can extend lifespan and suppresses age-related disease associated with protein misfolding across multiple model systems. These observations raise fundamental questions: what endogenous small molecules sustain proteostasis during aging, can their supplementation prevent neurodegenerative (and other protein folding diseases) and slow the aging process?
PhD project: Therapeutic applications of small molecule modulators of proteostasis
Organisms across all domains of life employ the accumulation of small organic osmolytes, which include molecules such as betaine and taurine, to mitigate proteotoxic stress. Recent work has also demonstrated anti-aging properties of this molecules, through yet unclear mechanisms. This project aims at dissecting the mode of action of different osmolytes using human cellular model systems and C. elegans as a model of organismal aging. We would like to address the following questions:
The project is part of an ongoing collaboration between the Khmelinskii and Padeken groups, which gives you the opportunity to become an expert in a wide range of methods and experimental approaches. This includes transcriptomics, proteomics, cell and molecular biology, fluorescence microscopy and advanced high-throughput mutagenesis screening.
Qualification profile
Are you an ambitious scientist looking to push the boundaries of research while interacting with colleagues from multiple disciplines and cultures? Then joining the IPP is your opportunity to give your scientific career a flying start! All you need is:
We offer
The deadline for applications is 15 October 2026. Interviews will take place at IMB in Mainz on 18+19 January 2027. Starting date: 1 February - 31 July 2027